Repeated Intracerebroventricular Administration of Glucagon-Like Peptide-1-(7-36) Amide or Exendin-(9-39) Alters Body Weight in the Rat* *This work was supported by the United Kingdom Medical Research Council.

Central nervous system glucagon-like peptide-1-(7–36) amide (GLP-1) administration has been reported to acutely reduce food intake in the rat. We here report that repeated intracerebroventricular (icv) injection of GLP-1 or the GLP-1 receptor antagonist, exendin-(9–39), affects food intake and body weight. Daily icv injection of 3 nmol GLP-1 to schedule-fed rats for 6 days caused a reduction in food intake and a decrease in body weight of 16 ± 5 g (P < 0.02 compared with saline-injected controls). Daily icv administration of 30 nmol exendin-(9–39) to schedule-fed rats for 3 days caused an increase in food intake and increased body weight by 7 ± 2 g (P < 0.02 compared with saline-injected controls). Twice daily icv injections of 30 nmol exendin-(9–39) with 2.4 nmol neuropeptide Y to ad libitum-fed rats for 8 days increased food intake and increased body weight by 28 ± 4 g compared with 14 ± 3 g in neuropeptide Y-injected controls (P < 0.02). There was no evidence of tachyphylaxis in response to icv GLP-1 o...

[1]  F. Talamantes,et al.  Galanin regulates prolactin release and lactotroph proliferation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. J. Larsen,et al.  Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. , 1998, Diabetes.

[3]  C. Strader,et al.  Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats. , 1998, Obesity research.

[4]  A. Astrup,et al.  Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. , 1998, The Journal of clinical investigation.

[5]  S. Woods,et al.  Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats , 1998, Brain Research.

[6]  P. Wellman,et al.  Decreased Intake of a Liquid Diet in Nonfood-Deprived Rats Following Intra-PVN Injections of GLP-1 (7–36) Amide , 1997, Pharmacology Biochemistry and Behavior.

[7]  D. Smith,et al.  Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. J. Larsen,et al.  Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. , 1997, Endocrinology.

[9]  S. Bloom,et al.  Leptin interacts with glucagon‐like peptide‐1 neurons to reduce food intake and body weight in rodents , 1997, FEBS letters.

[10]  Yihong Wang,et al.  Novel signal transduction and peptide specificity of glucagon‐like peptide receptor in 3T3‐L1 adipocytes , 1997, Journal of cellular physiology.

[11]  S. Woods,et al.  University of Groningen Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats , 2002 .

[12]  R. Palmiter,et al.  Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y , 1996, Science.

[13]  E. Blázquez,et al.  Colocalization of Glucagon‐Like Peptide‐1 (GLP‐1) Receptors, Glucose Transporter GLUT‐2, and Glucokinase mRNAs in Rat Hypothalamic Cells: Evidence for a Role of GLP‐1 Receptor Agonists as an Inhibitory Signal for Food and Water Intake , 1996, Journal of neurochemistry.

[14]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[15]  P. J. Larsen,et al.  Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. , 1996, The American journal of physiology.

[16]  S. Woods,et al.  Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. , 1996, The American journal of physiology.

[17]  R. Seeley,et al.  Identification of targets of leptin action in rat hypothalamus. , 1996, The Journal of clinical investigation.

[18]  J. Habener,et al.  Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. , 1996, Endocrinology.

[19]  R. Palmiter,et al.  Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y , 1996, Nature.

[20]  S. Bloom,et al.  Central glucagon-like peptide-I in the control of feeding. , 1996, Biochemical Society transactions.

[21]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[22]  I. Valverde,et al.  Glucagon-like peptide-1 binding to rat skeletal muscle , 1995, Peptides.

[23]  J. Bue-Valleskey,et al.  The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.

[24]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[25]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[26]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[27]  G. Bray,et al.  Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity , 1994, Peptides.

[28]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[29]  S. Kanai,et al.  Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene , 1994, Neuroscience Letters.

[30]  M. G. Dube,et al.  Evidence that neuropeptide Y is a physiological signal for normal food intake , 1994, Brain Research.

[31]  B. Göke,et al.  Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. , 1993, The Journal of biological chemistry.

[32]  P. Lambert,et al.  A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation. , 1993, Endocrinology.

[33]  S. Leibowitz,et al.  Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect , 1992, Peptides.

[34]  M. G. Dube,et al.  Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Sanacora,et al.  Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. , 1990, Endocrinology.

[36]  S. Bloom,et al.  Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus , 1989, Brain Research.

[37]  S. Leibowitz,et al.  Repeated hypothalamic stimulation with neuropeptide Y increases daily carbohydrate and fat intake and body weight gain in female rats , 1989, Physiology & Behavior.

[38]  C. Sladek,et al.  Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: Stimulation of feeding and the release of corticosterone, vasopressin and glucose , 1988, Brain Research Bulletin.

[39]  S. Kalra,et al.  Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus , 1988, Peptides.

[40]  J. Morley,et al.  Effect of neuropeptide Y on ingestive behaviors in the rat. , 1987, The American journal of physiology.

[41]  S. Leibowitz,et al.  Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity , 1986, Peptides.

[42]  E. Stricker,et al.  Oxytocin and vasopressin secretion in response to stimuli producing learned taste aversions in rats. , 1986, Behavioral neuroscience.

[43]  S. Leibowitz,et al.  Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Rosenwasser,et al.  Interactions between nocturnal feeding and wheel running patterns in the rat , 1985, Physiology & Behavior.

[45]  S. Leibowitz,et al.  Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. , 1984, Life sciences.

[46]  J. Morley,et al.  Neuropeptide Y: A potent inducer of consummatory behavior in rats , 1984, Peptides.

[47]  G. Collier,et al.  A cost-benefit analysis of nocturnal feeding in the rat , 1983, Physiology & Behavior.

[48]  J. A. Deutsch,et al.  Cholecystokinin produces bait shyness in rats , 1977, Nature.

[49]  P. Wellman,et al.  PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[50]  T. Miyoshi,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Melanin-Concentrating Hormone Acutely Stimulates Feeding, But Chronic Administration Has No Effect on , 2022 .

[51]  D. Smith,et al.  Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. , 1997, Endocrinology.

[52]  D. Smith,et al.  Neuropeptide Y Induced Feeding in the Rat Is Mediated by a Novel Receptor1. , 1997, Endocrinology.

[53]  D. Smith,et al.  Glucagon-like peptide-1 is a physiological incretin in rat. , 1995, The Journal of clinical investigation.

[54]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[55]  I. Valverde,et al.  Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue. , 1993, Endocrinology.

[56]  C. Orskov.  Glucagon-like peptide-1, a new hormone of the entero-insular axis. , 1992, Diabetologia.

[57]  J. Eng.  Exendin peptides. , 1992, The Mount Sinai journal of medicine, New York.

[58]  N. Ling,et al.  The effects of chronic central administration of corticotropin-releasing factor on food intake, body weight, and hypothalamic-pituitary-adrenocortical hormones. , 1991, Life sciences.